[Dysplasia and laryngeal carcinoma in situ]
- PMID: 22282009
- DOI: 10.1007/s00106-011-2424-7
[Dysplasia and laryngeal carcinoma in situ]
Abstract
Although the glottis is amenable to chemotherapy, currently most lesions from stage I laryngeal dysplasia up to carcinoma in situ are excised. This literature review presents selected molecular biological aspects especially in relation to dysplasia of the larynx and its therapy, as well as currently preferred biomarkers for chemotherapeutic prevention of laryngeal dysplasia.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
